Filing Details

Accession Number:
0001209191-23-035259
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-07 21:26:59
Reporting Period:
2023-06-05
Accepted Time:
2023-06-07 21:26:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1396814 Pacira Biosciences Inc. PCRX Pharmaceutical Preparations (2834) 510619477
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1900012 Anthony Molloy C/O Pacira Biosciences, Inc.
5401 West Kennedy Boulevard, Suite 890
Tampa FL 33609
Chief Lgl & Compliance Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-06-05 2,267 $38.28 17,398 No 4 S Direct
Common Stock Disposition 2023-06-06 4,521 $38.55 12,877 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
  2. Includes 215 shares of common stock acquired under the issuer's employee stock purchase plan in June 2022.
  3. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.